Inventor · disambiguated record
Thomas Jaquin
Also filed as: JAQUIN THOMAS · JAQUIN THOMAS JEAN
3 granted patents·5 pending applications·1 citations·filing 2007–2022
50Inventor score
Top patents by PatentIndex Score
8 records- 0171US10865250B2Anti-cancer fusion polypeptidePIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Dec 15, 2020·1 cites·8 claims
- 0259US2021198380A1Anti-cancer fusion polypeptidePIERIS PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 0351US2024228562A1Novel lipocalin muteins specific for connective tissue growth factor (ctgf)PIERIS PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 0447US8846868B2Anti-AREG/HB-EGF antibodies and treatmentCASWELL JILL·Filed 2009·Granted Sep 30, 2014·0 cites·11 claims
- 0546US2021246219A1Combination therapies comprising cd137/her2 bispecific agents and pd-1 axis inhibitors and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 0645US12486330B2Fusion proteins specific for CD137 and GPC3PIERIS PHARMACEUTICALS GMBH·Filed 2020·Granted Dec 2, 2025·0 cites·6 claims
- 0743US2022168387A1Inhaled administration of lipocalin muteinsPIERIS PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 0837US2010111965A1Combination therapyFUSION ANTIBODIES LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Jaquin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →